Navigation Links
Staging system in ALS shows potential tracks of disease progression, Penn study finds
Date:6/19/2013

PHILADELPHIA - The motor neuron disease Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, progresses in a stepwise, sequential pattern which can be classified into four distinct stages, report pathologists with the Perelman School of Medicine at the University of Pennsylvania in the Annals of Neurology. This post-mortem staging of ALS brain and spinal cord tissues shows, for the first time, how the fatal degenerative disease may progress from one starting point in the central nervous system to other regions of brain and spinal cord. As evidence mounts showing that other neurodegenerative diseases, such as Alzheimer's and Parkinson's, transmit disease-specific pathological proteins from cell-to-cell within the interconnected brain regions of affected individuals, this study suggests that a similar transmission process may be spreading toxic TDP-43 proteins and damaging motor neurons in the brain and spinal cord of ALS patients.

"Researchers at Penn and beyond can now start to investigate and try to confirm this transmission process in ALS, by looking for cell to cell transmission of TDP-43 in models of ALS," said senior author John Trojanowski, MD, PhD, director of the Penn Institute on Aging and professor of Pathology and Laboratory Medicine at Penn. "If this transmission process can be identified and understood in ALS, this opens a new pathway for treatments, such as immunotherapies that could interrupt or block damaged and destructive proteins from corrupting other cells, thus halting the spread of disease."

Researchers examined 76 autopsies of patients with ALS, measured pathological TPD-43 distribution and concentration in the nervous system, and were able to map out four distinct stages to assess the disease and burden of pathology.

  • In stage 1, TDP-43 pathology was found within the primary motor cortex, as well as neurons in the spinal cord and nerves in the brainstem involved with swallowing, breathing and movement.
  • Stage 2 added to stage 1, with TDP-43 progressing forward in the brain and into brainstem areas important for balance and posture.
  • In stage 3, TDP-43 pathology moved further forward in the frontal cortex and also to areas just behind the primary motor cortex.
  • By stage 4, TDP-43 lesions spread more widely to the temporal lobe and hippocampus, areas involved in memory and language comprehension.

The team evaluated genetic material in all but one of the ALS cases, and found that patients with a C9orf72 mutation had a shorter duration of disease (an average of 24 months vs 34 months in patients without the mutation), and while they had the same distribution pattern as ALS cases without the mutation, there was a greater buildup of pathology in each of the regions. 71 percent of patients with this C9orf72 mutation had a family history of ALS, frontotemporal degeneration (FTD) or another neurodegenerative disease, and 29 percent of cases with the C9orf72 mutation were apparently sporadic cases, lacking any ALS-linked genetic mutation.

The information gathered in these post-mortem autopsies mirrors what neurologists see in patients clinically. Future efforts may interrogate the process of disease progression further, work to identify biomarkers that can help detect the burden of disease in patients during life, and, most importantly, home in on therapies to arrest the progression of ALS.


'/>"/>

Contact: Kim Menard
kim.menard@uphs.upenn.edu
215-662-6183
University of Pennsylvania School of Medicine
Source:Eurekalert

Related medicine news :

1. Staging and risk stratification of thyroid cancer improved with SPECT/CT
2. PET/CT shows clear advantages over conventional staging for breast cancer patients
3. New imaging agent enables better cancer detection, more accurate staging
4. Differences in staging and treatment likely to be behind UKs low bowel cancer survival
5. IU, Regenstrief automated system aims to improve child health
6. Scientists tailor cell surface targeting system to hit organelle ZIP codes
7. Physicians call for improvements to countrys public health system to protect US residents
8. New research finds no association between white potato consumption (baked, boiled mashed) and obesity, Type 2 diabetes or systemic inflammation
9. Is it time for regional cardiovascular emergency care systems across the US?
10. How does the immune system fight off threats to the brain? New research yields fresh insight
11. Decision support system translates into high percentage of positive chest CT examinations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... announced that it is launching a new client service center in La Vergne, ... Texas, and will provide the full range of Empyrean client services. , “Our ...
(Date:5/3/2016)... GA (PRWEB) , ... May 03, 2016 , ... Nationally recognized personal injury law firm ... Day weekend by giving free roses to anyone who wants one for their Mother or ... we recognize the important valuable contributions of Mothers.” Monge goes on to say, “we ...
(Date:5/3/2016)... Texas (PRWEB) , ... May 03, 2016 , ... Park ... that live in or adjacent to the 75204, 75205, 75206, 75209, 75219, 75220, 75225, ... Lawn/Uptown, Greenway Parks, Bluffview, Midway Hollow, North Dallas, Plano, Preston Hollow and Park Cities ...
(Date:5/3/2016)... ... 2016 , ... United Benefit Advisors (UBA), the nation’s leading ... addition to its elite stable of Partner Firms. Benefits Alliance Insurance Services is ... Paul Vincent. The Firm is also led by industry and thought-leading COO Steve ...
(Date:5/3/2016)... ... May 03, 2016 , ... For the sixth ... and Communication Technology (ICT) companies in the annual Branham300 listing. For 23 years, ... Canada, as ranked by revenue. , “We are honored to be on ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 3, 2016 BioNovus ... Center,s Institute for Advancing Medical Innovation (IAMI) today ... new drugs, diagnostics and medical devices. ... Innovations with rights to license, develop and commercialize ... "This partnership represents a significant ...
(Date:5/3/2016)... , May 4, 2016 ... "Global Cancer Stem Cell Therapy Market Outlook 2020" ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,Recombinant technology has improved ... are expected to be developed in coming years. Many ... techniques. Cancer stem cell therapies are also expected to ...
(Date:5/3/2016)... a major investment from Sino-German High-Tech Fund to further expand product development, strengthen its disease modeling capabilities and increase ... ... ... ... ...
Breaking Medicine Technology: